stock.name

Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

AMRX

Market Cap$2.08B
Close$

Compare Amneal Pharmaceuticals

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Amneal Pharmaceuticals Inc - Ordinary Shares - Class AAmneal Pharmaceuticals Inc - Ordinary Shares - Class A-12.40%265%0.9-42.3
marketMarket Avg53.21.27%29%-1.3
HealthcareHealthcare Avg29.71.32%16%7.31.3
$8.50

Target Price by Analysts

24.6% upsideAmneal Pharmaceuticals Target Price DetailsTarget Price
$19.69

Current Fair Value

188.6% upside

Undervalued by 188.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.08 Billion
Enterprise Value$4.73 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.78
Beta1.32
Outstanding Shares308,651,373
Avg 30 Day Volume1,617,666

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-12.35
PEG-1.01
Price to Sales0.85
Price to Book Ratio-6.82
Enterprise Value to Revenue1.9
Enterprise Value to EBIT17.36
Enterprise Value to Net Income-29
Total Debt to Enterprise0.57
Debt to Equity-42.28

Revenue Sources

No data

ESG Score

No data

About Amneal Pharmaceuticals Inc